Treatment of ACE inhibitor-induced cough

Pharmacotherapy

Volumn 19, Issue 7, 1999, Pages 804-810

  Luque, Carla A ^a,b   Vazquez Ortiz, Mariola ^a,c  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c FPA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUSSIVE AGENT; BACLOFEN; BENAZEPRIL; BENZONATATE; BRADYKININ; BUPIVACAINE; CAPTOPRIL; CROMOGLYCATE DISODIUM; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; FOSINOPRIL; LISINOPRIL; MOEXIPRIL; NEDOCROMIL SODIUM; OZAGREL; PICOTAMIDE; PROSTAGLANDIN E; QUINAPRIL; RAMIPRIL; RECEPTOR; SUBSTANCE P; SULINDAC; THEOPHYLLINE; THROMBOXANE A2; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE; TRANDOLAPRIL;

CLINICAL TRIAL; COUGHING; GENE; GENETIC POLYMORPHISM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; QUALITY OF LIFE; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COUGH; HUMANS;

EID: 0344604454     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.10.804.31563     Document Type: Review

References (42)

1. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992;327:685-91.
2. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction (CONSENSUS II). N Engl J Med 1992;327:678-84.
3. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-81.
4. Boulet LP, Milot J, Lampron N, Lacourciere Y. Pulmonary function and airway responsiveness during long-term therapy with captopril. JAMA 1989;261:413-16.
5. Sesoko S, Kaneko Y. Cough associated with the use of captopril. Arch Intern Med 1985;145:1524.
6. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992;117:234-42.
7. Ravid D, Lishner M, Lang R, Ravid M. Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol 1994;34:1116-20.
8. Hume AL, Murphy JL, Lauerman SE. Angiotensin-converting enzyme inhibitor-induced cough. Pharmacotherapy 1989;9(2): 88-90.
9. Fletcher AE, Palmer AJ, Bulpilt CJ. Cough with angiotensin converting enzyme inhibitors: how much of a problem? J Hypertens 1994;12(suppl 2):S43-7.
10. Sebastian JL, McKinney WP, Kaufman J, Young MJ. Angiotensin-converting enzyme inhibitors and cough. Chest 1991;99:36-9.
11. Coulter DM, Edwards IR. Cough associated with captopril and enalapril. Br Med J 1987;294:1521-3.
12. Goldszer RC, Lilly LS, Solomon HS. Prevalence of cough during angiotensin-converting enzyme inhibitor therapy. Am J Med 1988;85:887.
13. Gibson GR. Enalapril-induced cough. Arch Intern Med 1989;149:2701-3.
14. Olsen CG. Delay of diagnosis and empiric treatment of angiotensin-converting enzyme inhibitor-induced cough in office practice. Arch Fam Med 1995;4:525-8.
15. Elliott WJ. Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects. Clin Pharmacol Ther 1996;60:582-8.
16. Woo KS, Norris RM, Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 1995;75:967-8.
17. Kaufman J, Riendl P, Schlueter DP. Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors. Chest 1989;95:544-8.
18. Fuller RW, Dixon CM, Cuss FMC, Barnes PJ. Bradykinin-induced bronchoconstriction in humans. Am Rev Respir Dis 1987;135:176-80.
19. Malini PL, Strocchi E, Zanardi M, Milani M, Ambrosioni E. Thromboxane antagonism and cough induced by angiotensin-converting enzyme inhibitor. Lancet 1997;350:15-18.
20. 2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors. Life Sci 1997;60:1583-8.
21. Yeo WW, Ramsay LE, Morice AH. ACE inhibitor cough: a genetic link? [letter]. Lancet 1991;337:187.
22. Just PM. The positive association of cough with angiotensin-converting enzyme inhibitors. Pharmacotherapy 1989;9:82-7.
23. Meneffe SA, Chesson R, Wall LL. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors. Obstet Gynecol 1998;91:853-4.
24. Webb D, Benjamin N, Collier J, Robinson B. Enalapril-induced cough [letter]. Lancet 1986;2:1094.
25. Bucknell CE, Neilly JB, Carter R, Stevenson RD, Semple PF. Bronchial hyperreactivity in patients who cough after receiving angiotensin-converting enzyme inhibitors. Br Med J 1988;296:86-8.
26. Mitchell A, Gillies A, Carney S, Smith AJ. Cough and captopril [letter]. Arch Intern Med 1986;146:1017.
27. Bates B. Cough and hemoptysis. A guide to physical examination, 5th ed. Philadelphia: JB Lippincott, 1991:76.
28. Puolijoki H, Nieminen M, Moilanen E, et al. Cough induced by enalapril but not by captopril. Eur Respir J 1989;2: 289-91.
29. Sharif MN, Evans BL, Pylpchuk GB. Cough induced by quinapril with resolution after changing to fosinopril. Ann Pharmacother 1994;28:720-2.
30. Allen TL, Gora-Harper ML. Cromolyn sodium for ACE inhibitor-induced cough. Ann Pharmacother 1997;31:773-5.
31. Hargreaves MR, Benson MK. Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet 1995;345:13-6.
32. Hargreaves M. Sodium cromoglycate: a remedy for ACE inhibitor-induced cough. Br J Clin Pract 1993;47:319-20.
33. Aldis WL. Cromolyn for cough due to angiotensin-converting enzyme inhibitor therapy [letter]. Chest 1991;100:1741-2.
34. Keogh A. Sodium cromoglycate prophylaxis for angiotensin-converting enzyme inhibitor cough [letter]. Lancet 1993;341:560.
35. Puolijoki H, Rekiaro M. Lack of effect of nedocromil sodium in ACE-inhibitor-induced cough [letter]. Lancet 1995;345:394.
36. Dicpinigaitis PV. Use of baclofen to suppress cough induced by angiotensin-converting enzyme inhibitors. Ann Pharmacother 1996;30:1242-5.
37. Persson CGA, Draco AB. Xanthines as airway anti-inflammatory drugs. J Allergy Clin Immunol 1988;81:615-16.
38. Cazzola M, Matera MG, Liccardi G, De Frisco F, D'Amato G, Rossi F. Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough. Respiration 1993;60:212-15.
39. Pomari C, Turco P, Negro RD. Has theophylline a role in the cure and prevention of ACE-inhibitor-related cough? Respiration 1989;55:119-21.
40. Nichols MG, Gilchrist NL. Sulindac and cough induced by converting enzyme inhibitors [letter]. Lancet 1987;1:872.
41. McEwan JR, Choudry NB, Fuller RW. The effect of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Ther 1990;255:161-4.
42. Brown RC, Turton CWG. Cough and angiotensin converting enzyme inhibition [letter]. Br Med J 1988;296:1741.